This year, Curebound is proud to welcome one of the world’s most celebrated and beloved artists: P!NK Tickets on sale now! Since bursting onto the scene in 2000, P!NK has built a career defined by fearless honesty, unforgettable live shows, and a refusal to fit a mold. Across nine studio albums and a greatest hits collection,...
Clinical execution and pharmacovigilance are often managed in parallel rather than in partnership. For sponsors, that disconnect can create avoidable delays, inconsistent safety decision-making, protocol amendments, and added pressure on sites and study teams. In early-phase and complex trials, where risk profiles are still emerging, these gaps can have a direct impact on both patient...
This online event brings together pharmaceutical and biotechnology companies with contract development and manufacturing organizations (CDMOs) specializing in mammalian cell culture–based biologics production. Through a series of concise presentations, participating CDMOs showcase their capabilities across the biologics development lifecycle, including cell line development, upstream and downstream process development, scale-up, and GMP manufacturing. The event is...
This event brings together pharmaceutical and biotech professionals, CDMOs, and technology providers to discuss the development and manufacturing of highly potent active pharmaceutical ingredients (HPAPIs). This event shares presentations focused on key topics such as containment technologies, process scale-up, regulatory compliance, and occupational safety in HPAPI manufacturing. The event also serves as a networking platform...
The move toward self-administered, home-based treatments has made drug–device combination products a strategic priority. Success now requires tight integration across formulation, device design, testing, human factors, and regulatory strategy—not separate workflows. This session outlines the key decisions and capabilities for successful programs, including choosing platform vs. custom devices, ensuring formulation–device compatibility, and meeting testing standards....
What if advancing the 3Rs also improved your timelines, budgets, and scientific outcomes? This webinar challenges the perceived tradeoff between the 3Rs and operational performance in colony management. We will explore how a thoughtful combination of IVF, cryopreservation, electroporation, genotyping, and digital colony management can reduce animal use, stabilize genetic backgrounds, and simplify day to...
BVS in partnership with Related Beal, LLC inviting you to our Biotech Community Event in the heart of Boston's Seaport district. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. We are inviting all research scientists from the institutes, biotech/pharma,...
Cleanroom ISO classification is a foundational decision that directly impacts facility design, GMP manufacturing operations, and regulatory outcomes in biotech and pharmaceutical environments. This is especially critical in cell and gene therapy, viral vector, API, mRNA, and sterile ATMP manufacturing, where product protection, biohazard containment, and operator safety must be carefully balanced. In this webinar,...
Watch Leading CDMOs share their current capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process optimization and scale-up, which...
We are very excited to announce our outdoor Biotech Community Event at the Biovista Life Science Campus. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. ✨ What to Expect: Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge...
